Levonorgestrel Intrauterine Device versus Combined Transcervical Resection of the Endometrium in the Management of Adenomyosis: A Randomized Clinical Trial.

The quality-of-life (WHO QOL-BREF) and menorrhagia multi-attribute scale scores at 12 months were also significantly better in the transcervical resection of the endometrium + levonorgestrel intrauterine device arm.

None of the women in the combined transcervical resection of the endometrium and levonorgestrel intrauterine device group had levonorgestrel intrauterine device expulsion at 12 months compared to the levonorgestrel intrauterine device expulsion rate of 8.8% in the levonorgestrel intrauterine device alone group ( P = 0.013).